In Bergen I am affiliated with the Precision Oncology Group of Prof Emmet MacCormack. I am affiliated with the Competence Centre for Hereditary Cancer at Haukeland University Hospital, where I collaborate with the head, Hildegunn Høberg Vetti.
AS head of the Norwegian Cancer Genomics Consortium I collaborate with cancer scientists across Norway, and through the Norwegian Sarcoma Consortium with all Norwegian sarcoma centres. My main research collaborators are Kjetil Boye and Leonardo A Meza-Zepeda at Oslo University Hospital , — Radiumhospitalet, with whom I now have a joint postdoc position on the NoSarC project in Oslo.
Together with the US SARC028 trial group, headed by Dr Hussein Tawbi, now at MD Anderson, we will investigate predictive biomarkers for immune checkpoint therapy in sarcoma together with the Norwegian bioinformatics company OncoImmunity, headed by Richard Stratford. We also have a collaboration identifying immune markers in sarcoma patients.
We collaborate with Prof David Thomas, head of the Kinghorn cancer Centre in Sydney and Dr Andy Wagner at the Dana Farber Cancer Institute in Boston on Translational research on liposarcoma, funded by the Liddy Shriver Sarcoma Initiative.